š° Charitable Planning News
Page 5 - Charitable Planning News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Charitable Planning. Real-time updates on events, politics, business and more.
July 6, 2022
Many public companies are beginning preparations for filing quarterly reports on Form 10-Q for the second quarter of calendar 2022. As they do so, they should review and consider the U.S. Securities and Exchange Commission (SEC) guidance for public companies regarding disclosures pertaining to Russias invasion of Ukraine. The guidance includes a list of disclosure considerations, as well as aā¦
June 23, 2022
On May 25, 2022, the U.S. Food and Drug Administration (FDA) issued a guidance document intended to help pharmacists and wholesale drug distributors understand and comply with its final rule regarding the import of certain prescription drugs from Canada. The 2020 final rule, titled "Importation of Prescription Drugs," implemented Sections 804(b) through (h) of the Federal Food, Drug, and Cosmeticā¦
June 16, 2022
On June 15, 2022, Silicon Valley Clean Energy (SVCE) and Google announced that they have completed an agreement to create a fundamentally new 24/7 renewable energy service that features hourly renewable energy matching, integrated demand management, and a commitment to ongoing community investments in local building and transportation electrification. Under the 10-year agreement, SVCE will serveā¦
June 14, 2022
Fassett Joins Wilson Sonsiniās Colorado Office as a Partner; Firm Continues to Grow Its Corporate Life Sciences Practice and Its Mountain West Region Presence Contact:Kelsey DellovoBaretz+Brunelle339.223.0961 Mobilekdellovo@baretzbrunelle.com PALO ALTO, CA (June 14, 2022) ā Wilson Sonsini Goodrich & Rosati, the premier provider of legal services to technology, life sciences, and growth enterprisesā¦
June 13, 2022
On April 27, 2022, Vice Chancellor Sam Glasscock of the Delaware Court of Chancery issued an opinion, on a motion to dismiss, addressing several important governance topics about director and officer compensationāincluding where some members of management might constitute controlling stockholders. In this caseāKnight v. Miller 1 āthe plaintiff, a stockholder of Universal Health Services, Inc. (UHSā¦
June 8, 2022
On May 27, 2022, the California Privacy Protection Agency (CPPA) released a much-anticipated first draft of some of the anticipated regulations implementing the California Privacy Rights Act (CPRA).1 The release accompanied the CPPAās announcement of its next public meeting on June 8, 2022, where the agency will, among other agenda items, consider possible action regarding the draft regulationsā¦
June 7, 2022
Zoli Joins Wilson Sonsini as a Partner as the Firm Expands Its Focus on Energy and Climate Solutions; She Formerly Led the Energy, Renewables & Sustainability Group at Another Global Law Firm Contact:Kelsey DellovoBaretz+Brunelle339.223.0961 Mobilekdellovo@baretzbrunelle.com PALO ALTO, CA (June 7, 2022) ā Wilson Sonsini Goodrich & Rosati, the premier provider of legal services to technology, lifeā¦
June 3, 2022
Companies with employees or independent contractors who work or reside in Washington State should take heed that Washingtons Silenced No More Act (the act) goes into effect on June 9, 2022. The act places substantial limits on what may be included in some of the most common agreements that employers enter into with their workers. On and after June 9, 2022, employers could find that their existingā¦
June 2, 2022
On April 28, 2022, the U.S. District Court for the Central District of California granted the defendants motion for summary judgment, holding that, taking facts in the light most favorable to the plaintiff, defendant Kineticflix LLC did not violate plaintiff Alla Anatoleyvna Zorikovas copyright when Kineticflix rented physical copies of Zorikovas ballet instructional DVD. The court held thatā¦
May 20, 2022
In May 2022, the Center for Drug Evaluation and Research (CDER) of the U.S. Food and Drug Administration (FDA) announced the launch of a new program for expediting the development of new treatment options for rare diseasesāAccelerating Rare disease Cures (ARC) Program.1 The FDA considers a disease that affects fewer than 200,000 people in the U.S. a rare disease, and estimates that more than 30ā¦